6 Einträge gefunden

1. Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials

   1. Bieber, T
   2. Thyssen, J P
   3. Reich, K
   4. Simpson, E L
   5. Katoh, N
   6. Torrelo, A
   7. De Bruin-Weller, M

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Five-year efficacy and safety of tildrakizumab in patients with moderate-to-severe psoriasis who respond at week 28: pooled analyses of two randomized phase III clinical trials (reSURFACE 1 and reSURFACE 2)

   1. Thaci, D
   2. Piaserico, S
   3. Warren, R B
   4. Gupta, A K
   5. Cantrell, W
   6. Draelos, Z
   7. Foley, P

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
3. Continued treatment with secukinumab is associated with high retention or regain of response

   1. Augustin, M
   2. Thaci, D
   3. Eyerich, K
   4. Pinter, A
   5. Radtke, M
   6. Lauffer, F
   7. Mrowietz, U

   2020 - Forschungsinformationssystem des UKE
4. Gender and age significantly determine patient needs and treatment goals in psoriasis - a lesson for practice

   1. Maul, J-T
   2. Navarini, A A
   3. Sommer, R
   4. Anzengruber, F
   5. Sorbe, C
   6. Mrowietz, U
   7. Drach, M

   2019 - Forschungsinformationssystem des UKE
5. Topology of psoriasis in routine care: results from high-resolution analysis of 2009 patients

   1. Augustin, M
   2. Sommer, R
   3. Kirsten, N
   4. Danckworth, A
   5. Radtke, M A
   6. Reich, K
   7. Thaci, D

   2019 - Forschungsinformationssystem des UKE
6. Drug safety of systemic treatments for psoriasis: Results from The German Psoriasis Registry PsoBest

   1. Reich, K
   2. Mrowietz, U
   3. Radtke, M A
   4. Thaci, D
   5. Rustenbach, S J
   6. Spehr, C
   7. Augustin, M

   2015 - Forschungsinformationssystem des UKE